Quality by Execution: a conceptual review of the execution layer in injectable pharmaceutical manufacturing
Year: 2026
Type: preprint
Abstract: Quality by Design (QbD) sets the acceptable operating ranges of a pharmaceutical process during development, and Quality by Control (QbC) keeps a running process inside those ranges through sensors and feedback loops. Neither asks, in a formal way, whether a defined step was actually carried out as written on the manufacturing floor, by people or by partly automated systems. This review examines that question for injectable products, where aseptic processing still depends on manual interventions. Regulations, guidance documents, published analyses of FDA inspection data and the human reliability literature were reviewed narratively. In FY 2024 Form 483 reports issued to pharmaceutical companies, 21 CFR 211.22(d), which requires the quality control unit's written procedures to be followed, was the most frequently cited provision (184 citations), followed by 211.192 on investigation of discrepancies (116). Published analyses point the same way. In biologics Form 483s issued from 2010 to 2025, failure to follow written procedures, to document contemporaneously and to investigate before batch release were the leading violations, at 34%, 21% and 14%. In a study of 85 warning letters, poor aseptic practice made up 31.5% of the sterile-manufacturing observations. The revised EU GMP Annex 1, applicable since August 2023, requires a contamination control strategy whose effectiveness is reviewed. Together these sources point to an execution layer that regulation already addresses but that, in the sources reviewed, neither QbD nor QbC covers explicitly. Quality by Execution (QbE) is proposed for this layer as the quality framework intended to ensure that manufacturing activities are executed, documented, and verified as specified. Its scope is set by a three-question boundary test and five activity domains, and it is positioned against QbD, QbC and the closest behavioural approach found, Critical Behavioral Attributes. The supporting evidence consists of citation counts and not of measured execution failure rates, and the proposal has not been validated. Testing candidate execution-fidelity indicators on a fill-finish line is the next step. Preprint, version 1. This manuscript has not been peer reviewed. AI use: The author solely conceived, created, and wrote this manuscript. Microsoft Copilot and Grammarly were used exclusively for language editing, grammar correction, and improving readability. The author reviewed and approved all edits and assumes full responsibility for the accuracy, integrity, and originality of the final work.
Author: Pandey, Nitesh Kumar
Language: English
Topic: Healthcare Regulation
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W7237238024
